Skip to main content

Table 1 Bayesian adaptive designs explored for the Collaborative Ankle Support Trial

From: Bayesian adaptive designs for multi-arm trials: an orthopaedic case study

Design

Interim analysis schedulea

Arm allocation

Control allocation

Early stopping

1

None

1:1:1:1

Equal to other arms

None

2

Every 200 patients

1:1:1:1

Equal to other arms

Efficacy or futility every 200 patients

3

Every 50 patients

Arm dropping assessed at each interim analysis

Equal to other arms

Efficacy or futility every 200 patients

4

Every 50 patients

RAR at each analysis

Matched to best intervention arm

Efficacy or futility every 200 patients

5

Every 50 patients

RAR at each analysis

Fixed at 40%

Efficacy or futility every 200 patients

6

Every 50 patients

RAR at each analysis

No designated control; tubular bandage is treated as an intervention arm

Efficacy or futility every 200 patients

  1. RAR Response adaptive randomisation
  2. aAt number of patients due for primary outcome follow up (at 12 weeks post-randomisation)